학술논문
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial
Document Type
Article
Author
Source
In: European Heart Journal . (European Heart Journal, 14 August 2022, 43(31):2958-2967)
Subject
Language
English
ISSN
15229645
0195668X
0195668X